Skip to main content
. 2017 Nov 10;85(1):55–62. doi: 10.1016/j.bjorl.2017.10.009

Table 4.

Histopathological blind grading findings of each group.

Groups Histopathological Blind Grading
Mean ± standard deviation (min–max)
Cytoplasmic vacuolization Cellular degeneration Dilatation Apoptotic cell Nerve degeneration
Control group 0.25 ± 0.46 (0–1) 0.13 ± 0.36 (0–1) 0.13 ± 0.36 (0–1) 0.63 ± 0.52 (0–1) 0.25 ± 0.46 (0–1)
Sham group 0.38 ± 0.52 (0–1) 0 0.25 ± 0.46 (0–1) 0.50 ± 0.53 (0–1) 0.25 ± 0.46 (0–1)
Whortleberry control group 0.75 ± 0.71 (0–2) 0.88 ± 0.99 (0–2) 0.75 ± 0.89 (0–2) 0.50 ± 0.53 (0–1) 0.38 ± 0.52 (0–1)
Cisplatin group 3.63 ± 0.52 (3–4) 3.13 ± 0.35 (3–4) 2.63 ± 0.74 (2–4) 3.00 ± 0.00 (3–3) 2.50 ± 0.53 (2–3)
Cisplatin + 100 mg/kg whortleberry group 1.75 ± 0.46 (1–2) 1.63 ± 0.52 (1–2) 1.75 ± 0.46 (1–2) 2.75 ± 0.46 (2–3) 2.13 ± 0.83 (1–3)
Cisplatin + 200 mg/kg whortleberry group 0.88 ± 0.64 (0–2) 0.88 ± 0.83 (0–2) 0.50 ± 0.53 (0–1) 1.00 ± 0.76 (0–2) 1.50 ± 0.76 (0–2)